High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis

Author:

Fürst Daniel12,Müller Carlheinz34,Vucinic Vladan5,Bunjes Donald6,Herr Wolfgang7,Gramatzki Martin8,Schwerdtfeger Rainer9,Arnold Renate10,Einsele Hermann11,Wulf Gerald12,Pfreundschuh Michael13,Glass Bertram14,Schrezenmeier Hubert12,Schwarz Klaus12,Mytilineos Joannis124

Affiliation:

1. Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg–Hessen, and

2. Institute of Transfusion Medicine, University of Ulm, Ulm, Germany;

3. Zentrales Knochenmarkspender-Register für Deutschland, Ulm, Germany;

4. Deutsches Register für Stammzelltransplantationen (DRST), Ulm, Germany;

5. Department of Hematology/Oncology, University of Leipzig, Leipzig, Germany;

6. Department of Internal Medicine III, University of Ulm, Ulm, Germany;

7. Department of Medicine III, Johannes Gutenberg-University Mainz, Mainz, Germany;

8. Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Kiel, Germany;

9. Centre for Bone Marrow and Blood Stem Cell Transplantation, Deutsche Klinik für Diagnostik, Wiesbaden, Germany;

10. Hematology/Oncology Department, Charité Campus Virchow Berlin, Berlin, Germany;

11. Department of Medicine II, University Hospital Würzburg, Würzburg, Germany;

12. Department of Hematology/Oncology, Georg-August-University Göttingen, Göttingen, Germany;

13. Department Internal Medicine I, Universitätsklinikum des Saarlandes, Homburg, Germany; and

14. Department of Hematology/Oncology, Asklepios Klinik St. Georg, Hamburg, Germany

Abstract

Key Points HLA mismatches at the allele and antigen level (possibly with the exception of HLA-DQB1) should be treated equally in donor selection. HLA mismatches at >1 locus (including HLA-DQB1) have additive detrimental effects.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference42 articles.

1. Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients.;Slavin;Transplantation,2004

2. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation.;Shaw;Br J Haematol,2010

3. Pasquini MC Wang Z Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides 2011. Available at: http://www.cibmtr.org. Accessed May 19, 2013

4. Trends of hematopoietic stem cell transplantation in the third millennium.;Gratwohl;Curr Opin Hematol,2009

5. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.;Giebel;Blood,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3